Please contact us with any questions or if you'd like to explore your legal rights
Name 
Email Address 
Phone 
Message 

UPDATE: SAFETY LABELING CHANGES FOR NUVARING®

On January 31, 2008, the FDA posted safety related labeling changes for NuvaRing®. The changes include a:
  • Warning that users have increased risk of arterial thrombotic and thromboembolic events as well as hypertension
  • Warning that women using NuvaRing® who have a history of acquired thrombophilia, hyperlipidemia and obesity are at increased risk for stroke
  • Warning that users with migraines have increased risk of stroke
  • Warning that older women should take lowest dose possible
  • Warning that women with hypertension should not use NuvaRing®
  • Precaution that some users with hyperlipidemia have developed pancreatitis
  • Precaution about severe depression in users
  • Precaution about rare reports of vaginal or cervical erosion or ulceration with NuvaRing® use
  • Rare reports about insertion of the ring into the urinary bladder
The new prescribing information is available at FDA.gov.

To find out more information or if you or a loved one have suffered any adverse effects as a result of using NuvaRing®, please contact attorney Carmen S. Scott at (843) 216-9160.
Please contact us with any questions or if you'd like to explore your legal rights.